CHARACTERIZATION OF RECEPTORS FOR HUMAN RECOMBINANT INTERFERON-γ IN HUMAN CELLS

  • AKINAGA SHIRO
    Pharmaceutical Research Laboratories, Kyowa Hakko Kogyo Co., Ltd.
  • GOMI KATSUSHIGE
    Pharmaceutical Research Laboratories, Kyowa Hakko Kogyo Co., Ltd.
  • OKA TETSUO
    Pharmaceutical Research Laboratories, Kyowa Hakko Kogyo Co., Ltd.
  • MORIMOTO MAKOTO
    Pharmaceutical Research Laboratories, Kyowa Hakko Kogyo Co., Ltd.

この論文をさがす

抄録

Highly purified human recombinant interferon-γ (ReIFN-γ) was radioiodinated with ^<125>I-Bolton-Hunter reagent and used to characterize the receptor for ReIFN-γ. ^<125>I ReIFN-γ specifically and saturably bound four human cells tested, FL, WISH, Daudi, and HL-60,which were reported to have ReIFN-γ binding sites. Scatchard analysis of the binding data of FL cells revealed the presence of 5200 binding sites per cell and a K_d value of 2.1×10^<-10>M. Although the binding of ^<125>I ReIFN-γ was inhibited by unlabelled natural IFN-γ and ReIFN-γ, it was not inhibited by unlabelled human ReIFN-α and ReIFN-β, suggesting that receptors for (Re) IFN-γ were different from those for IFN-α or IFN-β. However, ReIFN-γ displaced the binding of ^<125>I ReIFNγ 3 to 5 times more effectively than IFN-γ. Internalization of ^<125>I ReIFN-γ bound to the cell surface receptor was observed at 37℃. Pretreatment of FL cells with unlabeled ReIFN-γ caused a concentration-dependent down-regulation in the ReIFN-γ receptor, which was specific for IFN-γ and reversible. From these studies, we concluded that although the ReIFN-γ is not identical to putative IFN-γ, the recombinant form binds to the same binding sites for IFN-γ and does not bind to the binding sites for IFN-α or β.

収録刊行物

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ